Maya Vizeva

Maya Vizeva

Auto-generated profile, based on publicly available information

Maya Vizeva

Medical College “Yordanka Filaretova”, Medical University – Sofia, Sofia, Bulgaria

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 July 2026 in Pharmacia
Verified
Journal Article
Open access
PDF file
MVMaya Vizeva
Maya Vizeva
SVStoyan Vizev
Stoyan Vizev
RMRossen Mihaylov
Rossen Mihaylov
EHEvelin Hayvazov
Evelin Hayvazov
Chronic diseases, multimorbidity, and the prolonged use of medications are gradually transforming pharmacotherapy into a long-term and organizationally complex process involving numerous participants and sources of information. This article aims to analyze the organizational implications of prolonged multiprofessional pharmacotherapy in chronic diseases and the importance of the traceability, consistency, and connectivity of information to the quality and sustainability of treatment. A conceptual and analytical approach was applied based on a thematic and interpretive review of the scientific literature related to chronic diseases, long-term pharmacotherapy, interprofessional collaboration, continuity of care, and the role of the patient. The findings indicate that as the duration of treatment increases, decisions, participants, and sources of information gradually accumulate, increasing the organizational complexity of treatment and its dependence on information traceability and connectivity. This creates conditions for partial therapeutic visibility, organizational vulnerability, and disrupted continuity in long-term multiprofessional pharmacotherapy. The role of the patient becomes particularly important, as they often remain the most consistent participant in treatment while simultaneously bearing the consequences of insufficient coordination and incomplete information. Improved traceability, professional coordination, documentation, pharmaceutical care, and digital support may contribute to greater safety, sustainability, and quality of long-term pharmacotherapy in chronic diseases.

1 September 2026 in Acta Medica Bulgarica
Verified
Journal Article
Open access
PDF file
MVM. Vizeva
M. Vizeva
SVS. Vizev
S. Vizev
Geriatric care in Bulgaria is undergoing a complex transformation driven by accelerated ageing of the population, increasing multimorbidity and a growing need for long-term support. The analysis identifies major systemic barriers, including fragmentation between health and social services, the absence of a unified regulatory framework, insufficient development of home and community-based care, workforce shortages, and limited digital infrastructure. The lack of interdisciplinary teams and standardized comprehensive geriatric assessment (CGA) contributes to inefficiency, frequent hospitalizations, and reduced continuity of care. Despite these constraints, Bulgaria demonstrates emerging efforts in active ageing policy, community services, and digital health tools, although their impact remains limited. Diqitalization and artificial intelligence present significant opportunities for improving access, coordination, and quality of services, but their implementation requires strong ethical, legal, and human-centered foundations. A transition towards an integrated care model, expansion of community-based services, professional training, quality regulation, and support for informal caregivers is crucial to ensure equitable, humane, and sustainable geriatric care in Bulgaria.

27 February 2026 in Pharmacia
Verified
Journal Article
Open access
PDF file
MVMaya Vizeva
Maya Vizeva
AVAlexandrina Vodenicharova
Alexandrina Vodenicharova
SVStoyan Vizev
Stoyan Vizev
TDTsvetomir Dimitrov
Tsvetomir Dimitrov
TDTanya Dimitrova
Tanya Dimitrova
Chronic pharmacotherapy poses significant challenges for contemporary pharmaceutical practice due to its long-term nature and dependence on sustained patient engagement. Medication non-adherence remains a major cause of suboptimal therapeutic outcomes and increased health care costs, highlighting the growing importance of pharmaceutical care. This article presents a narrative and conceptual review of the professional responsibility of the pharmacist in chronic pharmacotherapy, focusing on medication adherence as a key ethical and economic dimension of pharmaceutical practice. Professional responsibility is conceptualised as a longitudinal and shared process embedded in routine pharmaceutical care, extending beyond regulatory compliance. The analysis also addresses the impact of digital health technologies on pharmaceutical practice, emphasising the continuing role of professional judgement and accountability. The article affirms the pharmacist’s position as a key professional actor in long-term medication management and health system sustainability.